- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Taysha Gene Therapies Stock (NASDAQ:TSHA), Quotes and News Summary
Taysha Gene Therapies Stock (NASDAQ: TSHA)
| Day Range1.87 - 2.22 | 52 Wk Range1.68 - 12.17 | Open / Close2.15 / 2.02 | Float / Outstanding20.6M / 41.1M |
| Vol / Avg.108.8K / 108.2K | Mkt Cap83M | P/E- | 50d Avg. Price3.57 |
| Div / Yield- | Payout Ratio- | Total Float20.6M | EPS-0.84 |
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-09 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.910 | -0.840 | 0.0700 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Taysha Gene Therapies Questions & Answers
You can purchase shares of Taysha Gene Therapies (NASDAQ: TSHA) through any online brokerage.
Other companies in Taysha Gene Therapies’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Fortress Biotech (NASDAQ:FBIO), OncoCyte (NASDAQ:OCX), Sesen Bio (NASDAQ:SESN) and Finch Therapeutics Group (NASDAQ:FNCH).
The latest price target for Taysha Gene Therapies (NASDAQ: TSHA) was reported by Wedbush on Friday, August 12, 2022. The analyst firm set a price target for 5.00 expecting TSHA to rise to within 12 months (a possible 147.52% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Taysha Gene Therapies (NASDAQ: TSHA) is $2.02 last updated September 29, 2022, 8:00 PM UTC.
There are no upcoming dividends for Taysha Gene Therapies.
Taysha Gene Therapies’s Q3 earnings are confirmed for Wednesday, November 9, 2022.
There is no upcoming split for Taysha Gene Therapies.
Taysha Gene Therapies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.